Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record history now shows a new revision v3.7.0 added and the previous revision v3.6.6 removed, reflecting an updated version of the study record.
    Difference
    0.1%
    Check dated 2026-09-15T20:30:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The revision tag in the study history updated from v3.6.5 to v3.6.6. This indicates a new internal revision entry has been posted to the record.
    Difference
    0.1%
    Check dated 2026-09-01T18:01:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.5 has been added to the study record history. The previous revision entry v3.6.4 has been removed.
    Difference
    0.1%
    Check dated 2026-08-11T08:09:12.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the study record history, replacing the previous v3.6.3 entry. This reflects a minor backend page update and does not change study data or reported results.
    Difference
    0.1%
    Check dated 2026-07-28T03:07:00.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces v3.6.2 in the history. This reflects a platform update to the page.
    Difference
    0.1%
    Check dated 2026-07-06T16:29:17.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.2 was added to the study's record history, and the previous revision v3.6.0 was removed. This reflects an update to the documented revision history for the record.
    Difference
    0.1%
    Check dated 2026-06-29T10:48:15.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.